ARCHIVES

Advocates Oppose Proposals to Market Drugs After Phase I.

This article is from The Cancer Letter archive.

Vol. 32 No. 22 | June 9, 2006

Download PDF Visit The Full Archive

Related Articles

CIDAC Bids Not Limited To Cancer Research Centers

January 17, 1975

Low Percentage Of Trials Published In Medical Journals

October 31, 2008

Extramural Advisory Board Members Listed

October 20, 1995

NCI Publishes FOA For Trials Network Program

July 27, 2012

NIH Alternative Medicine Office Releases RFA For Grant Awards

April 9, 1993

Rosenberg Begins Trial To Immunize Patient against Tumor

October 11, 1991